Yokneam-based medical equipment maker Syneron Medical today announced that its Polaris DS device for non-invasive hair removal had received CE Mark approval for sales throughout Europe.
Syneron says Polaris DS is based on proprietary Electro-Optical Synergy technology, called ELOS, which combines optical energy and electrical energy.
ELOS technology also provides the basis for several other aesthetic medical systems from Syneron, including the Aurora DS hair removal system and Aurora SR skin rejuvenation system, which utilize a combination of light and conducted RF energies. Aurora DS and Aurora SR have already received both CE Mark and FDA clearance. The company is now in the process of applying for FDA approval on Polaris DS.
According to Syneron, Polaris DS is unique in its use of both diode laser (light) energy and conducted RF energy for effective, safe and comfortable hair removal.
The company said it would immediately begin Europe-wide sales efforts on the Polaris device.
Founded in 2000, Syneron’s headquarters and R&D center is located in Israel. Its sales, service and support subsidiaries are located in located in Toronto, Canada and Grunwald, Germany.
In a lawsuit filed October 28 in United States District Court for the Central District of California, Israeli medical equipment firm Lumenis (Nasdaq: LUME) sued Syneron, its subsidiaries and 10 unknown defendants for infringement of the company's US patents. The suit sought unspecified damages as well as “a preliminary and permanent injunction against the continued infringement of these patents”.
On November 3, Syneron said Lumenis's request for a temporary restraining order had been dismissed by a US federal judge.
Published by Globes [online] - www.globes.co.il - on 28 November, 2002